Westfield, NJ, United States of America

Ulf H Dolling




Average Co-Inventor Count = 3.2

ph-index = 7

Forward Citations = 142(Granted Patents)


Company Filing History:


Years Active: 1980-2009

Loading Chart...
Loading Chart...
Loading Chart...
28 patents (USPTO):Explore Patents

Title: Innovations by Ulf H. Dolling: A Leader in HIV Research and Patent Development

Introduction

Ulf H. Dolling, based in Westfield, NJ, is a prolific inventor and researcher known for his significant contributions to the field of medicinal chemistry, particularly in the development of compounds targeting HIV. With a portfolio of 28 patents, he has been instrumental in creating innovative solutions for the prevention and treatment of HIV and AIDS.

Latest Patents

Among his latest patents, one notable work involves HIV integrase inhibitors, specifically Hydroxy (tetra- or hexa-)hydronaphthyridine dione compounds of Formula I. These compounds serve as inhibitors of HIV integrase and help combat HIV replication. They are designed to be useful in the prevention and treatment of HIV infection and AIDS, either as compounds themselves or in the form of pharmaceutically acceptable salts. Furthermore, they can be incorporated into pharmaceutical compositions and potentially combined with other antivirals, immunomodulators, antibiotics, or vaccines.

Another important patent focuses on the stereoselective synthesis of a 4,4-disubstituted cyclohexanepropanoic acid. This invention presents a stereoselective route to a compound of formula I, where R represents either hydrogen or an alkali metal, with aromatic representations illustrating 4-chlorophenyl and 2,5-difluorophenyl. These innovations highlight Dolling’s commitment to advancing therapeutic options in virology.

Career Highlights

Ulf H. Dolling has worked with prominent organizations such as Merck & Company, Inc. and Merck Sharp & Dohme Corporation. His work in these esteemed pharmaceutical companies has allowed him to collaborate with leading experts and drive forward impactful research initiatives in the field of infectious diseases.

Collaborations

Throughout his career, Dolling has collaborated with various professionals, including notable coworkers such as John M. Williams and Richard D. Tillyer. These partnerships have been essential in enhancing the development and effectiveness of his patented inventions, promoting innovation in the pharmaceutical landscape.

Conclusion

Ulf H. Dolling stands out as a significant figure in the pharmaceutical industry, particularly in HIV research. His impressive portfolio of patents reflects his dedication to innovation and improving health outcomes for individuals affected by HIV and AIDS. Through his ongoing research and collaborations, he continues to make strides in the fight against infectious diseases.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…